Classys (Bain Capital portfolio company) to acquire 18% of Ilooda for KRW 40.5bn
- Deal value
- $28m
- Stake
- 18%
- Implied 100%
- $155m
- Revenue
- $32m
- Op. income
- $6m
- Multiples
- EQV/EBIT 27.1xPSR 4.9x
Deal value ÷ stake (structure unconfirmed)
2022 연결 · DART-verified
2022 연결 · DART-verified
On implied equity value
DART 20230321000803
- Target
- Ilooda · Aesthetic medical devices
- Buyer
- Classys (Bain Capital portfolio company) · SI
- Seller
- CEO Kim Yong-han
- Structure
- —
- Announced
- Sep 4, 2023
- Closed
- —
- Stage
- Signed
Target
Ilooda is a KOSDAQ-listed aesthetic medical device company specializing in microneedle RF and laser systems. Its flagship 'Secret' series has reportedly sold more than 5,000 units cumulatively.
Deal rationale
Classys CEO Baek Seung-han said the two companies have distinct strengths in different product lines and regions and would focus on maximizing them through a close partnership. The company said holding a stake and collaborating strategically, rather than directly managing Ilooda, would better preserve Ilooda's strengths. The contract reportedly includes a call option on the largest shareholder's remaining shares, which could raise the stake to 36%. Edaily described the deal as one executed by Bain Capital through its portfolio company Classys.
| Revenue | $32m |
| Operating income | $6m |
| EBITDA | — |
| Net income | — |
2022 연결 · DART-verified · 20230321000803
Press coverage
- 파이낸셜뉴스(네이트) (2023-09-04): “클래시스, 이루다 지분 18% 인수”
- 이데일리 (2023-09-05): “이루다 지분 품은 클래시스”
- 이데일리 (2023-12-18): “405억원”
This is a data entry summarising filings and press reports. Please check the original sources for the figures.